Literature DB >> 17229811

Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle.

Christina M Alfieri1, Heather J Evans-Anderson, Katherine E Yutzey.   

Abstract

Skeletal muscle development and growth are regulated through multiple signaling pathways that include insulin-like growth factor I (IGF-I) and calcineurin activation of nuclear factor of activated T cell (NFAT) transcription factors. The developmental regulation and molecular mechanisms that control IGF-I gene expression in murine embryos and in differentiating C2C12 skeletal myocytes were examined. IGF-I is expressed in developing skeletal muscle, and its embryonic expression is significantly reduced in embryos lacking both NFATc3 and NFATc4. During development, the IGF-I exon 1 promoter is active in multiple organ systems, including skeletal muscle, whereas the alternative exon 2 promoter is expressed predominantly in the liver. The IGF-I exon 1 promoter flanking sequence includes two highly conserved regions that contain NFAT consensus binding sequences. One of these conserved regions contains a calcineurin/NFAT-responsive regulatory region that is preferentially activated by NFATc3 in C2C12 skeletal muscle cells and NIH3T3 fibroblasts. This NFAT-responsive region contains three clustered NFAT consensus binding sequences, and mutagenesis experiments demonstrated the requirement for two of these in calcineurin or NFATc3 responsiveness. Chromatin immunoprecipitation analyses demonstrated that endogenous IGF-I genomic sequences containing these conserved NFAT binding sequences interact preferentially with NFATc3 in C2C12 cells. Together, these experiments demonstrated that a NFAT-rich regulatory element in the IGF-I exon 1 promoter flanking region is responsive to calcineurin signaling and NFAT activation in skeletal muscle cells. The identification of a calcineurin/NFAT-responsive element in the IGF-I gene represents a potential mechanism of intersection of these signaling pathways in the control of muscle development and homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229811     DOI: 10.1152/ajpcell.00506.2006

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  7 in total

Review 1.  The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism?

Authors:  T van Wessel; A de Haan; W J van der Laarse; R T Jaspers
Journal:  Eur J Appl Physiol       Date:  2010-07-03       Impact factor: 3.078

Review 2.  The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle.

Authors:  Kunihiro Sakuma; Akihiko Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-04-01

3.  FoxO1 and FoxM1 transcription factors have antagonistic functions in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene regulation.

Authors:  Arunima Sengupta; Vladimir V Kalinichenko; Katherine E Yutzey
Journal:  Circ Res       Date:  2012-11-14       Impact factor: 17.367

4.  Muscle development and obesity: Is there a relationship?

Authors:  Charlotte A Maltin
Journal:  Organogenesis       Date:  2008-07       Impact factor: 2.500

5.  Multi-breed and multi-trait co-association analysis of meat tenderness and other meat quality traits in three French beef cattle breeds.

Authors:  Yuliaxis Ramayo-Caldas; Gilles Renand; Maria Ballester; Romain Saintilan; Dominique Rocha
Journal:  Genet Sel Evol       Date:  2016-04-23       Impact factor: 4.297

6.  IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells.

Authors:  Luisa Cironi; Nicolò Riggi; Paolo Provero; Natalie Wolf; Mario-Luca Suvà; Domizio Suvà; Vincent Kindler; Ivan Stamenkovic
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

7.  Atlas of tissue- and developmental stage specific gene expression for the bovine insulin-like growth factor (IGF) system.

Authors:  Mani Ghanipoor-Samami; Ali Javadmanesh; Brian M Burns; Dana A Thomsen; Greg S Nattrass; Consuelo Amor S Estrella; Karen L Kind; Stefan Hiendleder
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.